Pheochromocytoma secondary prevention

Pheochromocytoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Pheochromocytoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Pheochromocytoma secondary prevention On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Pheochromocytoma secondary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Pheochromocytoma secondary prevention
CDC on Pheochromocytoma secondary prevention
Pheochromocytoma secondary prevention in the news
Blogs on Pheochromocytoma secondary prevention
Directions to Hospitals Treating Pheochromocytoma
Risk calculators and risk factors for Pheochromocytoma secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Secondary Prevention

• Preoperative treatment of pheochromocytoma is the best way to reduce complications and improve morbidity by controlling hypertension during surgery and hypotension after it.
• All patients with pheochromoctoma need postoperative follow up:
  • Patients should undergo baseline postoperative biochemical testing and annual lifelong tests.
  • Noncatecholamine-producing tumor should undergo annual imaging with CT or MRI to monitor for recurrence.

References

Template:WikiDoc Sources